The equity only needs NuScale to cross from technical credibility into commercial credibility. A single financeable U.S. project, visible progress in Romania, and better supply readiness would shift the story from optionality to
backlog and attached lifecycle revenue. That should support a materially higher valuation, but not a full platform premium, because project timing, partner economics, and
dilution still cap upside.